{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:05:53Z","timestamp":1777579553005,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Our previous studies demonstrate that the major histocompatibility complex (MHC) is associated with the progression of esophageal squamous cell carcinoma (ESCC). HLA-DQA1, which belongs to the MHC Class II family, may be a potential biomarker in ESCC progression. However, the association between HLA-DQA1 and ESCC in high-incidence area of northern China has not been well characterized. The purpose of this study is to investigate the relationship of HLA-DQA1 expression with the progression and prognosis of ESCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We analyzed the expression profiles of HLA-DQA1 in esophageal cancer (EC) samples in the TCGA database and validated HLA-DQA1 expression by immunohistochemistry, western blotting, and quantitative reverse-transcription polymerase chain reaction in matched EC and normal tissues, respectively. The correlation between HLA-DQA1 expression and clinicopathologic characteristics of ESCC was further analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result:<\/jats:title>\n            <jats:p>Immunohistochemical analysis indicated that the expression level of HLA-DQA1 in ESCC tissues was significantly higher than the matched normal tissues (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). HLA-DQA1 mRNA and protein expression were significantly higher in ESCC tissues compared to the matched normal tissues. Patients with family history negative or with tumor sizes &gt;4\u200acm were associated with higher HLA-DQA1 expression levels. A prognostic significance of HLA-DQA1 was also found by the Log-rank method, in which high expression of HLA-DQA1 was correlated with a shorter overall survival time. The receiver operating characteristic (ROC) curve analysis yielded the area under the ROC curve value of 0.693. Univariate and multivariate analyses also suggest that high expression of HLA-DQA1 is a potential indicator for poor prognosis of ESCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our results demonstrate that HLA-DQA1 plays an important role in ESCC progression and may be a biomarker for ESCC diagnosis and prognosis, as well as a potential target for the treatment of patients with ESCC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014454","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T20:42:32Z","timestamp":1551386552000},"page":"e14454","source":"Crossref","is-referenced-by-count":20,"title":["High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China"],"prefix":"10.1097","volume":"98","author":[{"given":"Fang-Fang","family":"Shen","sequence":"first","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Pan","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Zhong","family":"Li","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Kuo","family":"Li","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Fen","family":"Su","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Duan","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Min","family":"Lun","sequence":"additional","affiliation":[{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory for Esophageal Cancer Research, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Qiang","family":"Tian","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Sun","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Huang","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Tian","family":"Cao","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-You","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang"},{"name":"Anyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren","year":"2017","journal-title":"Lancet"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ije\/10.2.127","article-title":"Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research","volume":"10","author":"Li","year":"1981","journal-title":"Int J Epidemiol"},{"key":"R5-20230914","first-page":"249","article-title":"Esophageal cancer in migrants from high- or low-risk areas in China","volume":"2","author":"Haocai","year":"1983","journal-title":"Ecol Dis"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000443155","article-title":"Etiology and prevention of esophageal cancer","volume":"3","author":"Yang","year":"2016","journal-title":"Gastrointest Tumors"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1010428317705013","DOI":"10.1177\/1010428317705013","article-title":"Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.3064","article-title":"Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"e90438","DOI":"10.1371\/journal.pone.0090438","article-title":"Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e0177494","DOI":"10.1371\/journal.pone.0177494","article-title":"Novel genetic locus at MHC region for esophageal squamous cell carcinoma in Chinese populations","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","article-title":"MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation","volume":"76","author":"Germain","year":"1994","journal-title":"Cell"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1155\/2013\/680302","article-title":"CD99 and HLA-II immunostaining in breast cancer tissue and their correlation with lymph node metastasis","volume":"34","author":"Baccar","year":"2013","journal-title":"Dis Markers"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00251-003-0563-z","article-title":"Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma","volume":"55","author":"Jordanova","year":"2003","journal-title":"Immunogenetics"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4161\/15592294.2014.969625","article-title":"HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC","volume":"9","author":"Hu","year":"2014","journal-title":"Epigenetics"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/00365520902998679","article-title":"Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression","volume":"44","author":"Liu","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/carcin\/22.10.1615","article-title":"DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas","volume":"22","author":"Nie","year":"2001","journal-title":"Carcinogenesis"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.7314\/APJCP.2014.15.5.2309","article-title":"Identification of a novel fusion gene (HLA-E and HLA-B) by RNA-seq analysis in esophageal squamous cell carcinoma","volume":"15","author":"Jiang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R19-20230914","first-page":"1783","article-title":"Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis","volume":"53","author":"Wang","year":"1993","journal-title":"Cancer Res"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1245\/s10434-013-2936-3","article-title":"Survival after recurrent esophageal carcinoma has not improved over the past 18 years","volume":"20","author":"Blom","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"62280","DOI":"10.18632\/oncotarget.11409","article-title":"Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence","volume":"7","author":"Ueda","year":"2016","journal-title":"Oncotarget"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.18632\/oncotarget.6900","article-title":"CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/cas.12296","article-title":"HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway","volume":"104","author":"Ge","year":"2013","journal-title":"Cancer Sci"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12032-013-0516-9","article-title":"Association of PYGO2 and EGFR in esophageal squamous cell carcinoma","volume":"30","author":"Moghbeli","year":"2013","journal-title":"Med Oncol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/ijc.27930","article-title":"PITX2: a promising predictive biomarker of patients\u2019 prognosis and chemoradioresistance in esophageal squamous cell carcinoma","volume":"132","author":"Zhang","year":"2013","journal-title":"Int J Cancer"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/0008-5472.CAN-10-4291","article-title":"Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/1078-0432.CCR-14-0879","article-title":"MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro","volume":"20","author":"Angell","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/MPA.0000000000000160","article-title":"Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response","volume":"43","author":"Ekkirala","year":"2014","journal-title":"Pancreas"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pbc.25359","article-title":"Going back to class I: MHC and immunotherapies for childhood cancer","volume":"62","author":"Haworth","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/s41598-017-04822-2","article-title":"GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10147-010-0056-7","article-title":"Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention","volume":"15","author":"Morita","year":"2010","journal-title":"Int J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902220-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:37:58Z","timestamp":1694720278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902220-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014454","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}